Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07612046 · ClinicalTrials.gov registry record
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 79
- Enrollment target
NCT07612046: Recruiting study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07612046 is a clinical trial that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07612046 is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a dedicated MRI scan of the pancreas (MRP) to better detect pancreatic cancer in people who are at a high risk for pancreatic cancer.
Interventions
- DIAGNOSTIC_TEST MRI
- DIAGNOSTIC_TEST Endoscopic ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2026-05-20 |
| Est. Completion | 2028-05-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07612046
The ClinicalTrials.gov registry entry for NCT07612046 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT07612046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07612046 about?
NCT07612046 is a clinical study titled "A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening". The purpose of this study is to develop a dedicated MRI scan of the pancreas (MRP) to better detect pancreatic cancer in people who are at a high risk for pancreatic cancer.
What is the current status of trial NCT07612046?
This trial is currently recruiting. The enrollment target is 79 participants. The study started on 2026-05-20. Estimated completion is 2028-05-20.
What interventions are being tested in trial NCT07612046?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST), Endoscopic ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07612046?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.